Ibipinabant

DB12649

small molecule investigational

Deskripsi

Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

Struktur Molekul 2D

Berat 487.4
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

839 Data
Cocaine Cocaine may increase the tachycardic activities of Ibipinabant.
Trospium The risk or severity of Tachycardia and drowsiness can be increased when Trospium is combined with Ibipinabant.
Oxyphenonium The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Ibipinabant.
Benzatropine The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Ibipinabant.
Disopyramide The risk or severity of Tachycardia and drowsiness can be increased when Disopyramide is combined with Ibipinabant.
Ipratropium The risk or severity of Tachycardia and drowsiness can be increased when Ipratropium is combined with Ibipinabant.
Metixene The risk or severity of Tachycardia and drowsiness can be increased when Metixene is combined with Ibipinabant.
Terfenadine The risk or severity of Tachycardia and drowsiness can be increased when Terfenadine is combined with Ibipinabant.
Buclizine The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with Ibipinabant.
Trihexyphenidyl The risk or severity of Tachycardia and drowsiness can be increased when Trihexyphenidyl is combined with Ibipinabant.
Oxyphencyclimine The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Ibipinabant.
Procyclidine The risk or severity of Tachycardia and drowsiness can be increased when Procyclidine is combined with Ibipinabant.
Profenamine The risk or severity of Tachycardia and drowsiness can be increased when Profenamine is combined with Ibipinabant.
Hyoscyamine The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Ibipinabant.
Methscopolamine bromide The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine bromide is combined with Ibipinabant.
Darifenacin The risk or severity of Tachycardia and drowsiness can be increased when Darifenacin is combined with Ibipinabant.
Tridihexethyl The risk or severity of Tachycardia and drowsiness can be increased when Tridihexethyl is combined with Ibipinabant.
Anisotropine methylbromide The risk or severity of Tachycardia and drowsiness can be increased when Anisotropine methylbromide is combined with Ibipinabant.
Atropine The risk or severity of Tachycardia and drowsiness can be increased when Atropine is combined with Ibipinabant.
Nicardipine The risk or severity of Tachycardia and drowsiness can be increased when Nicardipine is combined with Ibipinabant.
Pirenzepine The risk or severity of Tachycardia and drowsiness can be increased when Pirenzepine is combined with Ibipinabant.
Homatropine methylbromide The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Ibipinabant.
Benzquinamide The risk or severity of Tachycardia and drowsiness can be increased when Benzquinamide is combined with Ibipinabant.
Propantheline The risk or severity of Tachycardia and drowsiness can be increased when Propantheline is combined with Ibipinabant.
Dicyclomine The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Ibipinabant.
Biperiden The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with Ibipinabant.
Quinidine The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Ibipinabant.
Methantheline The risk or severity of Tachycardia and drowsiness can be increased when Methantheline is combined with Ibipinabant.
Cycrimine The risk or severity of Tachycardia and drowsiness can be increased when Cycrimine is combined with Ibipinabant.
Glycopyrronium The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Ibipinabant.
Tolterodine The risk or severity of Tachycardia and drowsiness can be increased when Tolterodine is combined with Ibipinabant.
Oxybutynin The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Ibipinabant.
Flavoxate The risk or severity of Tachycardia and drowsiness can be increased when Flavoxate is combined with Ibipinabant.
Diphenidol The risk or severity of Tachycardia and drowsiness can be increased when Diphenidol is combined with Ibipinabant.
Tiotropium The risk or severity of Tachycardia and drowsiness can be increased when Tiotropium is combined with Ibipinabant.
Solifenacin The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with Ibipinabant.
Isopropamide The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with Ibipinabant.
Mepenzolate The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with Ibipinabant.
Fesoterodine The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Ibipinabant.
Hexocyclium The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Ibipinabant.
Dimetindene The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with Ibipinabant.
Aclidinium The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with Ibipinabant.
Dexetimide The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with Ibipinabant.
Umeclidinium The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Ibipinabant.
Trimebutine The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with Ibipinabant.
Imidafenacin The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with Ibipinabant.
Butylscopolamine The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Ibipinabant.
Thonzylamine The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with Ibipinabant.
Methscopolamine The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with Ibipinabant.
Revefenacin The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Ibipinabant.
Oxitropium The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with Ibipinabant.
Propiverine The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with Ibipinabant.
Batefenterol The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with Ibipinabant.
Mebeverine The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with Ibipinabant.
Tropatepine The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with Ibipinabant.
Prifinium The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with Ibipinabant.
Piperidolate The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with Ibipinabant.
Benzilone The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with Ibipinabant.
Difemerine The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with Ibipinabant.
Phenglutarimide The risk or severity of Tachycardia and drowsiness can be increased when Phenglutarimide is combined with Ibipinabant.
Mazaticol The risk or severity of Tachycardia and drowsiness can be increased when Mazaticol is combined with Ibipinabant.
Etybenzatropine The risk or severity of Tachycardia and drowsiness can be increased when Etybenzatropine is combined with Ibipinabant.
Otilonium The risk or severity of Tachycardia and drowsiness can be increased when Otilonium is combined with Ibipinabant.
Poldine The risk or severity of Tachycardia and drowsiness can be increased when Poldine is combined with Ibipinabant.
Bevonium The risk or severity of Tachycardia and drowsiness can be increased when Bevonium is combined with Ibipinabant.
Rociverine The risk or severity of Tachycardia and drowsiness can be increased when Rociverine is combined with Ibipinabant.
Bornaprine The risk or severity of Tachycardia and drowsiness can be increased when Bornaprine is combined with Ibipinabant.
Etanautine The risk or severity of Tachycardia and drowsiness can be increased when Etanautine is combined with Ibipinabant.
Tiemonium iodide The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with Ibipinabant.
Dihexyverine The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with Ibipinabant.
Penthienate The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with Ibipinabant.
Diphemanil The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with Ibipinabant.
Camylofin The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with Ibipinabant.
Fenpiverinium The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with Ibipinabant.
Emetonium iodide The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with Ibipinabant.
Pipenzolate The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with Ibipinabant.
Timepidium The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with Ibipinabant.
Chlorphenoxamine The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with Ibipinabant.
Phentermine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Phentermine.
Midodrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Midodrine.
Norepinephrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Norepinephrine.
Phenylephrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Phenylephrine.
Phenylpropanolamine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Phenylpropanolamine.
Labetalol The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Labetalol.
Metaraminol The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Metaraminol.
Epinephrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Epinephrine.
Methoxamine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Methoxamine.
Orciprenaline The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Orciprenaline.
Phenmetrazine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Phenmetrazine.
Dobutamine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Dobutamine.
Pseudoephedrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Pseudoephedrine.
Ritodrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Ritodrine.
Terbutaline The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Terbutaline.
Oxymetazoline The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Oxymetazoline.
Dopamine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Dopamine.
Isoprenaline The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Isoprenaline.
Acebutolol The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Acebutolol.
Lisdexamfetamine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Lisdexamfetamine.
Fenoterol The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Fenoterol.
Ephedrine The risk or severity of Tachycardia can be increased when Ibipinabant is combined with Ephedrine.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul